Valuation: Terumo Corporation

Market Cap 3,265B 20.11B 17.64B 16.34B 15.04B 28.44B 1,925B 28.99B 195B 76.38B 945B 75.53B 73.88B P/E 2027 *
19.6x
P/E 2028 * 17.6x
Enterprise Value 3,341B 20.58B 18.05B 16.72B 15.38B 29.1B 1,970B 29.66B 199B 78.16B 967B 77.28B 75.59B EV / Sales 2027 *
2.7x
EV / Sales 2028 * 2.49x
Free-Float
97.07%
Yield 2027 *
1.61%
Yield 2028 * 1.8%
1 day+1.12%
1 week-1.97%
Current month-0.92%
1 month+0.64%
3 months+3.48%
6 months-2.34%
Current year-2.49%
1 week 2,184.5
Extreme 2184.5
2,350
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.12%-1.97%-10.04%+3.17% 19.99B
-1.30%-3.18%-29.87%-14.06% 164B
-0.06%+1.00%-6.51%-4.72% 107B
+0.63%+2.14%+2.65%+59.42% 59.04B
+2.02%-1.74%+42.83%+58.90% 51.72B
+1.24%-1.16%-13.19%-40.86% 41.87B
-1.01%-4.84% - - 34.7B
+1.39%+4.97%-10.96%-43.29% 28.93B
+1.51%+0.51%+60.13%-6.30% 24.99B
-0.04%+1.17%-4.43%-5.67% 21.05B
Average +0.56%-1.31%+3.40%+0.73% 55.33B
Weighted average by Cap. +0.08%-1.02%-5.54%+1.10%

Financials

2027 *2028 *
Net sales 1,236B 7.62B 6.68B 6.19B 5.69B 10.77B 729B 10.98B 73.75B 28.93B 358B 28.6B 27.98B 1,315B 8.1B 7.11B 6.58B 6.06B 11.45B 775B 11.68B 78.44B 30.77B 381B 30.42B 29.76B
Net income 166B 1.02B 894M 828M 762M 1.44B 97.6B 1.47B 9.87B 3.87B 47.93B 3.83B 3.75B 185B 1.14B 1B 927M 853M 1.61B 109B 1.64B 11.05B 4.33B 53.63B 4.28B 4.19B
Net Debt 75.69B 466M 409M 379M 349M 659M 44.63B 672M 4.51B 1.77B 21.92B 1.75B 1.71B 14.29B 88.04M 77.22M 71.52M 65.8M 124M 8.43B 127M 852M 334M 4.14B 331M 323M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
13/07/26 ¥2,213.50 +1.12% 3,004,900
10/07/26 ¥2,189.00 -1.73% 4,601,900
09/07/26 ¥2,227.50 -2.15% 3,400,200
08/07/26 ¥2,276.50 -2.04% 5,188,900
07/07/26 ¥2,324.00 +1.33% 4,707,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,213.50JPY
Average target price
2,961.54JPY
Spread / Average Target
+33.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock